1 of 2019 and that of 2018 respectively. The THB 28.51 million shift or 91.47%. Net Profit margin for Quarter 1 /2019 and Quarter 1 / 2018 were 20.62% and 15.47% respectively. Such 5.15% increase was
maintain in Q4. The subsidiary in Vietnam, HV, has continuously improving operation results after installations of new machines in the past year and the increase in working hours from 1 shift to 2 shifts
พัฒนาการที่ต่อยอดจากเดิม โดยปรับเปลี่ยนจุดมุ่งเน้น หรือ shift focus เพื่อตอบโจทย์ประเทศในการปรับตัวสู่เศรษฐกิจดิจิทัล เศรษฐกิจสีเขียว และเศรษฐกิจที่ลดความเหลื่อมล้ำจากการมีความเป็นอยู่ที่ดีของประชาชนอย่าง
% 51.41 63.64% 4. Livestock 11.47 3.62% 9.27 2.50% (2.20) (19.18%) Total Sales revenues 316.83 100.00% 371.33 100.00% 54.50 17.20% Such growth was driven by a surge in revenues from sales of companion
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
administrative expenses for the three months period ended 31 March 2018 and 2019 at THB 34.11 million and THB 40.14 million respectively. This equals to a surge of 17.68 % in administrative expenses year on year
& expenses (net of tax) from the comparing quarters, the normalized net profit would be approximately THB 72.8 million in 2Q19 comparing to THB 52.4 million in 2Q18 or a surge of 39% . Statement of Financial
. Tambon Tarsit, Amohoe Pluag-daeng, Rayong As of June 30, 2018 the Company and its subsidiary had a significant surge in trade and other receivables when compared to last year which was mainly from an
declared as the “Year of Shift”. It is the opportunity for the organization, high-ranking executives and staff to revise the business model in order for the organization to achieve stable growth and the goal